Expanding clinical laboratory tobacco product evaluation methods to loose-leaf tobacco vaporizers

Drug and Alcohol Dependence

Volumn 169, Issue , 2016, Pages 33-40

  Lopez, Alexa A ^a   Hiler, Marzena ^a   Maloney, Sarah ^a   Eissenberg, Thomas ^a   Breland, Alison B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Carbon monoxide; Electronic cigarette; Heat not burn products; Loose leaf tobacco vaporizer; Plasma nicotine

Indexed keywords

CARBON MONOXIDE; NICOTINE;

ARTICLE; BLOOD LEVEL; CARBON MONOXIDE BLOOD LEVEL; CLINICAL LABORATORY; DISEASE SEVERITY; ELECTRONIC CIGARETTE; EVALUATION STUDY; HUMAN; LOOSE LEAF TOBACCO VAPORIZER; NICOTINE BLOOD LEVEL; PRIORITY JOURNAL; SATISFACTION; SMOKING; SMOKING CESSATION; TOBACCO; TOBACCO INDUSTRY; UNITED STATES; VAPORIZER; WITHDRAWAL SYNDROME; ADOLESCENT; ADULT; BLOOD; FEMALE; LABORATORY; MALE; MIDDLE AGED; NEBULIZER; PUBLIC HEALTH; TOBACCO DEPENDENCE; VAPING; YOUNG ADULT;

ADOLESCENT; ADULT; CARBON MONOXIDE; ELECTRONIC CIGARETTES; FEMALE; HUMANS; LABORATORIES; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; NICOTINE; PUBLIC HEALTH; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO; TOBACCO USE DISORDER; VAPING; YOUNG ADULT;

EID: 84992128525     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.10.005     Document Type: Article

References (42)

1. Blank, M.D., Cobb, C.O., Kilgalen, B., Austin, J., Weaver, M.F., Shihadeh, A., Eissenberg, T., Acute effects of waterpipe tobacco smoking: a double-blind, placebo-control study. Drug Alcohol Depend. 116 (2011), 102–109, 10.1016/j.drugalcdep.2010.11.026.
2. Breland, A., Buchhalter, A., Evans, S., Eissenberg, T., Evaluating acute effects of potential reduced-exposure products for smokers: clinical laboratory methodology. Nicotine Tob. Res. 4 (2002), 131–140, 10.1080/1462220021000032780.
3. Breland, A., Kleykamp, B., Eissenberg, T., Clinical laboratory evaluation of potential reduced exposure products for smokers. Nicotine Tob. Res. 8 (2006), 727–738, 10.1080/14622200600789585.
4. Breland, A., Soule, E., Lopez, A., Ramôa, C., El‐Hellani, A., Eissenberg, T., Electronic cigarettes: what are they and what do they do?. Ann. N. Y. Acad. Sci., 2016, 10.1111/nyas.12977.
5. Buchhalter, A., Eissenberg, T., Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior. Nicotine Tob. Res. 2 (2000), 39–43, 10.1080/14622200050011286.
6. Buchhalter, A., Schrinel, L., Eissenberg, T., Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes. Nicotine Tob. Res. 3 (2001), 111–118, 10.1080/14622200110042636.
7. Caraballo, R., Pederson, L., Gupta, N., New tobacco products: do smokers like them?. Tob. Control 15 (2006), 39–44, 10.1136/tc.2005.012856.
8. Cobb, C.O., Shihadeh, A., Weaver, M.F., Eissenberg, T., Waterpipe tobacco smoking and cigarette smoking: a direct comparison of toxicant exposure and subjective effects. Nicotine Tob. Res. 13 (2011), 78–87, 10.1093/ntr/ntq212.
9. Cobb, C.O., Blank, M.D., Morlett, A., Shihadeh, A., Jaroudi, E., Karaoghlanian, N., Kilgalen, B., Austin, J., Weaver, M.F., Eissenberg, T., Comparison of puff topography, toxicant exposure, and subjective effects in low-and high-frequency waterpipe users: a double-blind, placebo-control study. Nicotine Tob. Res. 17 (2015), 667–674, 10.1093/ntr/ntu196.
10. Cox, L., Tiffany, S., Christen, A., Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob. Res. 3 (2001), 7–16, 10.1080/14622200124218.
11. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act, 2016. 81 FR 28973 (May10, 2016). Docket No. FDA-2014-N-0189.
12. Evans, S.E., Blank, M., Sams, C., Weaver, M.F., Eissenberg, T., Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender. Exp. Clin. Psychopharmacol. 14 (2006), 121–135, 10.1037/1064-1297.14.2.121.
13. Fagerström, K., Hughes, J., Rasmussen, T., Callas, P., Randomised trial investigating effect of a novel nicotine delivery device (eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit. Tob. Control 9 (2000), 327–333, 10.1136/tc.9.3.327.
14. Fagerström, K.O., Hughes, J.R., Callas, P.W., Long-term effects of the eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quitting. Nicotine Tob. Res. 4 (2002), 141–145, 10.1080/1462220021000032771.
15. Farsalinos, K.E., Spyrou, A., Stefopoulos, C., Tsimopoulou, K., Kourkoveli, P., Tsiapras, D., Voudris, V., Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers). Sci. Rep., 5, 2015, 10.1038/srep11269.
16. Foulds, J., Stapleton, J., Feyerabend, C., Vesey, C., Jarvis, M., Russell, M.A.H., Effects of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology (Berl.) 106 (1992), 421–427, 10.1007/BF02245429.
17. Grana, R., Benowitz, N., Glantz, S.A., E-cigarettes a scientific review. Circulation 129 (2014), 1972–1986, 10.1161/CIRCULATIONAHA.114.007667.
18. Gray, J.N., Breland, A.B., Weaver, M.F., Eissenberg, T., Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology. Nicotine Tobacco Res. 10:9 (2008), 1141–1148, 10.1080/14622200802323258.
19. Hajek, P., Etter, J.F., Benowitz, N., et al. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 109:11 (2014), 1801–1810, 10.1111/add.12659.
20. Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., Fagerström, K.O., The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br. J. Addict. 86 (1991), 1119–1127, 10.1111/j.1360-0443.1991.tb01879.x.
21. Hecht, S., Carmella, S., Kotandeniya, D., Pillsbury, M., Chen, M., Ransom, B., Vogel, R., Thompson, E., Murphy, S., Hatsukami, D., Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob. Res. 17 (2015), 704–709, 10.1093/ntr/ntu218.
22. Hughes, J.R., Keely, J.P., The effect of a novel smoking system-accord- on ongoing smoking and toxin exposure. Nicotine Tob. Res. 6 (2004), 1021–1027, 10.1080/14622200412331296011.
23. Hughes, J.R., Hatsukami, D., Signs and symptoms of tobacco withdrawal. Arch. General Psychiatry 43 (1986), 289–294.
24. Hughes, J.R., Keely, J.P., Callas, P.W., Ever users versus never users of a less risky cigarette. Psycholol. Addict. Behav. 19 (2005), 439–442, 10.1037/0893-164X.19.4.439.
25. Kalkhoran, S., Grana, R.A., Neilands, T.B., Ling, P.M., Dual use of smokeless tobacco or e-cigarettes with cigarettes and cessation. Am. J. Health Behav. 39:2 (2015), 277–284, 10.5993/AJHB.39.2.14.
26. Keppel, G., 1991. Design and Analysis, a Researcher's Handbook. Pearson, Englewood, New Jersey.
27. Lüdicke, F., Haziza, C., Weitkunat, R., Magnette, J., Evaluation of biomarkers of exposure in smokers switching to a carbon-heated tobacco product: a controlled, randomized, open-label 5-day exposure study. Nicotine Tob. Res. 18 (2016), 1606–1613, 10.1093/ntr/ntw022.
28. Lopez, A.A., Hiler, M.M., Soule, E.K., Ramôa, C.P., Karaoghlanian, N.V., Lipato, T., Breland, A.B., Shihadeh, A.L., Eissenberg, T., Effects of electronic cigarette liquid nicotine concentration on plasma nicotine and puff topography in tobacco cigarette smokers: a preliminary report. Nicotine Tob. Res. 18 (2016), 720–723, 10.1093/ntr/ntv182.
29. Papathanasiou, G., Mamali, A., Papafloratos, S., Zerva, E., Effects of smoking on cardiovascular function: the role of nicotine and carbon monoxide. Health Sci. J. 8 (2014), 274–290.
30. Pickworth, W.B., Bunker, E.B., Henningfield, J.E., Transdermal nicotine: reduction of smoking with minimal abuse liability. Psychopharmacology (Berl.) 115 (1994), 9–14, 10.1007/BF02244745.
31. ® and e-cigs) and traditional cigarettes: submicron particle behaviour in human respiratory system. Ann Ig 28:2 (2016), 109–112, 10.7416/ai.2016.2089.
32. Ramôa, C.P., Hiler, M.M., Spindle, T.R., Lopez, A.A., Karaoghlanian, N., Lipato, T., Breland, A.B., Shihadeh, A., Eissenberg, T., Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: a preliminary report. Tob. Control, 2015, 10.1136/tobaccocontrol-2015-052447.
33. Shiffman, S., Pillitteri, J.L., Burton, S.L., Di Marino, M.E., Smoker and ex-smoker reactions to cigarettes claiming reduced risk. Tob. Control 13 (2004), 78–84.
34. Spindle, T.R., Breland, A.B., Karaoghlanian, N.V., Shihadeh, A.L., Eissenberg, T., Preliminary results of an examination of electronic cigarette user puff topography: the effect of a mouthpiece-based topography measurement device on plasma nicotine and subjective effects. Nicotine Tob. Res. 17 (2015), 142–149, 10.1093/ntr/ntu186.
35. Spindle, T., Hiler, M., Breland, A., Karaoghlanian, N., Shihadeh, A.L., Eissenberg, T., The influence of a mouthpiece-based topography measurement device on electronic cigarette user's plasma nicotine concentration, heart rate, and subjective effects under directed and ad libitum use conditions. Nicotine Tob. Res., 2016, 10.1093/ntr/ntw174 ntw174 [epub ahead of print].
36. St Helen, G., Havel, C., Dempsey, D.A., Jacob, P., Benowitz, N.L., Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction 111 (2016), 535–544, 10.1111/add.13183.
37. Stevenson, S., A high-tech high: how the rise of the vaporizer is changing pot culture. Slate. July 2. 2014 Retrieved from http://www.slate.com/articles/technology/technology/2014/07/vaporizers_how_the_new_high_tech_devices_are_changing_marijuana_culture.html.
38. Tabuchi, T., Kiyohara, K., Hoshino, T., Bekki, K., Inaba, Y., Kunugita, N., Awareness and use of electronic cigarettes and heat-not-burn tobacco products in Japan. Addiction 111 (2016), 706–713, 10.1111/add.13231.
39. Vansickel, A.R., Cobb, C.O., Weaver, M.F., Eissenberg, T.E., A clinical laboratory model for evaluating the acute effects of electronic cigarettes: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol. Biomarkers 19 (2010), 1945–1953, 10.1158/1055-9965.EPI-10-0288.
40. Vansickel, A.R., Weaver, M.F., Eissenberg, T., Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction 07:8 (2012), 1493–1500, 10.1111/j.1360-0443.2012.03791.
41. Weaver, S.R., Majeed, B.A., Pechacek, T.E., Nyman, A.L., Gregory, K.R., Eriksen, M.P., Use of electronic nicotine delivery systems and other tobacco products among USA adults, 2014: results from a national survey. Int. J. Public Health 61:2 (2016), 177–188, 10.1007/s00038-015-0761-0.
42. Wills, TA, Knight, R., Williams, R.J., Pagano, I., Sargent, JD, Risk factors for exclusive e-cigarette use and dual e-cigarette use and tobacco use in adolescents. Pediatrics 5:1 (2015), e43–e51, 10.1542/peds.2014-0760.